Synopsys Inc (SNPS) stock
SNPSNasdaqServices-Prepackaged SoftwareFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Aug 26, 2026Score 12/3054% above fair value
$467.61−22.58 (-4.61%)
Close on Oct 30, 2026Market cap $89.61BP/E 82.6Yield –
Earnings
Synopsys's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Dec 9, 2026
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$2.48B
+42.4% on a year earlier
non-GAAP EPS, Q3 FY2026
$3.91
$3.39 a year earlier
Latest guidance
Raised
Aug 26, 2026 · 21 items
Quarterly results
Revenue and earnings per share from each of Synopsys's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Oct 31, 2026 | Dec 9, 2026Expected | – | – | – | – | – |
| Q3 FY2026ended Jul 31, 2026 | Aug 26, 2026after the close | $2.48B | +42.4% | $2.84 | $3.91 | Release |
| Q2 FY2026ended Apr 30, 2026 | May 27, 2026after the close | $2.28B | +41.9% | $0.09 | $3.35 | Release |
| Q1 FY2026ended Jan 31, 2026 | Feb 25, 2026after the close | $2.41B | +65.6% | $0.34 | $3.77 | Release |
| Q4 FY2025ended Oct 31, 2025 | Dec 10, 2025after the close | $2.26B | +37.8% | $2.39 | $2.90 | Release |
| Q3 FY2025ended Jul 31, 2025 | Sep 9, 2025after the close | $1.74B | +14.0% | $1.50 | $3.39 | Release |
| Q2 FY2025ended Apr 30, 2025 | May 28, 2025after the close | $1.60B | +10.2% | $2.24 | $3.67 | Release |
| Q1 FY2025ended Jan 31, 2025 | Feb 26, 2025after the close | $1.46B | -11.8% | $1.89 | $3.03 | Release |
| Q4 FY2024ended Oct 31, 2024 | Dec 4, 2024after the close | $1.64B | +2.3% | $1.79 | $3.40 | Release |
| Q3 FY2024ended Jul 31, 2024 | Aug 21, 2024after the close | $1.53B | +2.6% | $2.73 | $3.43 | Release |
| Q2 FY2024ended Apr 30, 2024 | May 22, 2024after the close | $1.46B | +4.3% | $1.92 | $3.00 | Release |
| Q1 FY2024ended Jan 31, 2024 | Feb 21, 2024after the close | $1.65B | +21.2% | $2.89 | $3.56 | Release |
| Q4 FY2023ended Oct 31, 2023 | Nov 29, 2023after the close | $1.60B | +24.5% | $2.26 | $3.17 | Release |
| Q3 FY2023ended Jul 31, 2023 | Aug 16, 2023after the close | $1.49B | +19.2% | $2.17 | $2.88 | Release |
| Q2 FY2023ended Apr 30, 2023 | May 17, 2023after the close | $1.40B | +9.1% | $1.76 | $2.54 | Release |
| Q1 FY2023ended Jan 31, 2023 | Feb 15, 2023after the close | $1.36B | +7.2% | $1.75 | $2.62 | Release |
| Q4 FY2022ended Oct 31, 2022 | Nov 30, 2022after the close | $1.28B | +11.5% | $0.99 | $1.91 | Release |
| Q3 FY2022ended Jul 31, 2022 | Aug 17, 2022after the close | $1.25B | – | $1.43 | $2.10 | Release |
| Q2 FY2022ended Apr 30, 2022 | May 18, 2022after the close | $1.28B | – | $1.89 | $2.50 | Release |
| Q1 FY2022ended Jan 31, 2022 | Feb 16, 2022after the close | $1.27B | – | $1.99 | $2.40 | Release |
| Q4 FY2021ended Oct 31, 2021 | Dec 1, 2021after the close | $1.15B | – | $1.28 | $1.82 | Release |
| Q3 FY2021ended Jul 31, 2021 | Aug 18, 2021after the close | – | – | – | – | Filing |
| Q2 FY2021ended Apr 30, 2021 | May 19, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Jan 31, 2021 | Feb 17, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Oct 31, 2020 | Dec 2, 2020after the close | – | – | – | – | Filing |
| Q3 FY2020ended Jul 31, 2020 | Aug 19, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Synopsys's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenue | Q4 FY2026 | $2.53B – $2.58B | – | New | Aug 26, 2026 |
| GAAP EPSGAAP | Q4 FY2026 | $0.60 – $0.85 | – | New | Aug 26, 2026 |
| Non-GAAP EPSnon-GAAP | Q4 FY2026 | $4.10 – $4.16 | – | New | Aug 26, 2026 |
| GAAP ExpensesGAAP | Q4 FY2026 | $2.23B – $2.30B | – | New | Aug 26, 2026 |
| Non-GAAP Expensesnon-GAAP | Q4 FY2026 | $1.45B – $1.48B | – | New | Aug 26, 2026 |
| Non-GAAP Interest and Other Income (Expense), netnon-GAAP | Q4 FY2026 | -$119.00M – -$115.00M | – | Lowered | Aug 26, 2026 |
| Non-GAAP Tax Ratenon-GAAP | Q4 FY2026 | 18% | – | New | Aug 26, 2026 |
| Outstanding Shares (fully diluted) | Q4 FY2026 | 192 – 194 | – | New | Aug 26, 2026 |
| Revenue | FY2026 | $9.69B – $9.74B | $9.63B – $9.71B | Raised | Aug 26, 2026 |
| GAAP Operating MarginGAAP | FY2026 | 10.4% | – | New | Aug 26, 2026 |
| Non-GAAP Operating Marginnon-GAAP | FY2026 | 41.5% | – | New | Aug 26, 2026 |
| GAAP EPSGAAP | FY2026 | $3.84 – $4.08 | $2.49 – $2.91 | Raised | Aug 26, 2026 |
| Non-GAAP EPSnon-GAAP | FY2026 | $15.04 – $15.10 | $14.72 – $14.80 | Raised | Aug 26, 2026 |
| Free Cash Flownon-GAAP | FY2026 | $2.60B | $1.90B | Raised | Aug 26, 2026 |
| Free Cash Flow | FY2026 | $2.00B | – | New | May 27, 2026 |
| Capital Expenditures | FY2026 | $225.00M | $300.00M | Lowered | Aug 26, 2026 |
| GAAP ExpensesGAAP | FY2026 | $8.67B – $8.74B | – | New | Aug 26, 2026 |
| Non-GAAP Expensesnon-GAAP | FY2026 | $5.67B – $5.70B | – | New | Aug 26, 2026 |
| Non-GAAP Interest and Other Income (Expense), netnon-GAAP | FY2026 | -$485.00M – -$481.00M | – | Lowered | Aug 26, 2026 |
| Non-GAAP Tax Ratenon-GAAP | FY2026 | 18% | 18% | Reaffirmed | Aug 26, 2026 |
| Operating Cash Flow | FY2026 | $2.80B | $2.30B | Raised | Aug 26, 2026 |
| Outstanding Shares (fully diluted) | FY2026 | 192 – 194 | 192 – 194 | Reaffirmed | Aug 26, 2026 |
Guidance vs results
The last range Synopsys gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | EPS (GAAP) | $0.84 – $0.98 | $2.84 | Above range |
| Q3 FY2026 | Non-GAAP EPS | $3.63 – $3.69 | $3.91 | Above range |
| Q3 FY2026 | Revenue | $2.41B – $2.46B | $2.48B | Above range |
| Q2 FY2026 | EPS (GAAP) | $0.23 – $0.43 | $0.09 | Below range |
| Q2 FY2026 | Non-GAAP EPS | $3.11 – $3.17 | $3.35 | Above range |
| Q2 FY2026 | Revenue | $2.23B – $2.28B | $2.28B | Within range |
| Q1 FY2026 | EPS (GAAP) | $0.22 – $0.41 | $0.34 | Within range |
| Q1 FY2026 | Non-GAAP EPS | $3.52 – $3.58 | $3.77 | Above range |
| Q1 FY2026 | Revenue | $2.37B – $2.42B | $2.41B | Within range |
| FY2025 | EPS (GAAP) | $5.03 – $5.16 | $8.02Σ4Q | Above range |
| FY2025 | Non-GAAP EPS | $12.76 – $12.80 | $12.99Σ4Q | Above range |
| FY2025 | Revenue | $7.03B – $7.06B | $7.05BΣ4Q | Within range |
| Q4 FY2025 | EPS (GAAP) | -$0.27 – -$0.16 | $2.39 | Above range |
| Q4 FY2025 | Non-GAAP EPS | $2.76 – $2.80 | $2.90 | Above range |
| Q4 FY2025 | Revenue | $2.23B – $2.26B | $2.26B | Within range |
| Q3 FY2025 | EPS (GAAP) | $2.63 – $2.74 | $1.50 | Below range |
| Q3 FY2025 | Non-GAAP EPS | $3.82 – $3.87 | $3.39 | Below range |
| Q3 FY2025 | Revenue | $1.76B – $1.79B | $1.74B | Below range |
| Q2 FY2025 | EPS (GAAP) | $2.21 – $2.33 | $2.24 | Within range |
| Q2 FY2025 | Non-GAAP EPS | $3.37 – $3.42 | $3.67 | Above range |
| Q2 FY2025 | Revenue | $1.59B – $1.62B | $1.60B | Within range |
| Q1 FY2025 | EPS (GAAP) | $1.81 – $1.95 | $1.89 | Within range |
| Q1 FY2025 | Non-GAAP EPS | $2.77 – $2.82 | $3.03 | Above range |
| Q1 FY2025 | Revenue | $1.44B – $1.47B | $1.46B | Within range |
| Q4 FY2024 | EPS (GAAP) | $2.25 – $2.39 | $1.79 | Below range |
| Q4 FY2024 | Non-GAAP EPS | $3.27 – $3.32 | $3.40 | Above range |
| Q4 FY2024 | Revenue | $1.61B – $1.64B | $1.64B | Within range |
| Q3 FY2024 | EPS (GAAP) | $2.22 – $2.35 | $2.73 | Above range |
| Q3 FY2024 | Non-GAAP EPS | $3.25 – $3.30 | $3.43 | Above range |
| Q3 FY2024 | Revenue | $1.51B – $1.54B | $1.53B | Within range |
| Q2 FY2024 | EPS (GAAP) | $2.05 – $2.16 | $1.92 | Below range |
| Q2 FY2024 | Non-GAAP EPS | $3.09 – $3.14 | $3.00 | Below range |
| Q2 FY2024 | Revenue | $1.56B – $1.59B | $1.46B | Below range |
| Q1 FY2024 | EPS (GAAP) | $2.40 – $2.50 | $2.89 | Above range |
| Q1 FY2024 | Non-GAAP EPS | $3.40 – $3.45 | $3.56 | Above range |
| Q1 FY2024 | Revenue | $1.63B – $1.66B | $1.65B | Within range |
| Q4 FY2023 | EPS (GAAP) | $2.17 – $2.28 | $2.26 | Within range |
| Q4 FY2023 | Non-GAAP EPS | $3.01 – $3.06 | $3.17 | Above range |
| Q4 FY2023 | Revenue | $1.57B – $1.60B | $1.60B | Above range |
| Q3 FY2023 | EPS (GAAP) | $1.88 – $1.99 | $2.17 | Above range |
| Q3 FY2023 | Non-GAAP EPS | $2.70 – $2.75 | $2.88 | Above range |
| Q3 FY2023 | Revenue | $1.47B – $1.50B | $1.49B | Within range |
| Q2 FY2023 | EPS (GAAP) | $1.62 – $1.72 | $1.76 | Above range |
| Q2 FY2023 | Non-GAAP EPS | $2.45 – $2.50 | $2.54 | Above range |
| Q2 FY2023 | Revenue | $1.36B – $1.39B | $1.40B | Above range |
| Q1 FY2023 | EPS (GAAP) | $1.89 – $2.00 | $1.75 | Below range |
| Q1 FY2023 | Non-GAAP EPS | $2.48 – $2.53 | $2.62 | Above range |
| Q1 FY2023 | Revenue | $1.34B – $1.37B | $1.36B | Within range |
| Q4 FY2022 | EPS (GAAP) | $1.06 – $1.18 | $0.99 | Below range |
| Q4 FY2022 | Non-GAAP EPS | $1.80 – $1.85 | $1.91 | Above range |
| Q4 FY2022 | Revenue | $1.26B – $1.29B | $1.28B | Within range |
| Q3 FY2022 | EPS (GAAP) | $1.32 – $1.44 | $1.43 | Within range |
| Q3 FY2022 | Non-GAAP EPS | $2.01 – $2.06 | $2.10 | Above range |
| Q3 FY2022 | Revenue | $1.21B – $1.24B | $1.25B | Above range |
| Q2 FY2022 | EPS (GAAP) | $1.67 – $1.78 | $1.89 | Above range |
| Q2 FY2022 | Non-GAAP EPS | $2.35 – $2.40 | $2.50 | Above range |
| Q2 FY2022 | Revenue | $1.24B – $1.27B | $1.28B | Above range |
| Q1 FY2022 | EPS (GAAP) | $1.75 – $1.92 | $1.99 | Above range |
| Q1 FY2022 | Non-GAAP EPS | $2.35 – $2.40 | $2.40 | Within range |
| Q1 FY2022 | Revenue | $1.25B – $1.28B | $1.27B | Within range |
Guidance history
Every forecast Synopsys put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 26, 2026 | Capital Expenditures | FY2026 | $225.00M | Lowered |
| Aug 26, 2026 | Non-GAAP EPS | FY2026 | $15.04 – $15.10 | Raised |
| Aug 26, 2026 | Non-GAAP EPS | Q4 FY2026 | $4.10 – $4.16 | New |
| Aug 26, 2026 | GAAP EPS | FY2026 | $3.84 – $4.08 | Raised |
| Aug 26, 2026 | GAAP EPS | Q4 FY2026 | $0.60 – $0.85 | New |
| Aug 26, 2026 | Free Cash Flow | FY2026 | $2.60B | Raised |
| Aug 26, 2026 | GAAP Operating Margin | FY2026 | 10.4% | New |
| Aug 26, 2026 | Non-GAAP Operating Margin | FY2026 | 41.5% | New |
| Aug 26, 2026 | Outstanding Shares (fully diluted) | FY2026 | 192 – 194 | Reaffirmed |
| Aug 26, 2026 | Non-GAAP Tax Rate | FY2026 | 18% | Reaffirmed |
| Aug 26, 2026 | Operating Cash Flow | FY2026 | $2.80B | Raised |
| Aug 26, 2026 | GAAP Expenses | FY2026 | $8.67B – $8.74B | New |
| Aug 26, 2026 | Non-GAAP Expenses | FY2026 | $5.67B – $5.70B | New |
| Aug 26, 2026 | Non-GAAP Interest and Other Income (Expense), net | FY2026 | -$485.00M – -$481.00M | Lowered |
| Aug 26, 2026 | Outstanding Shares (fully diluted) | Q4 FY2026 | 192 – 194 | New |
| Aug 26, 2026 | Non-GAAP Tax Rate | Q4 FY2026 | 18% | New |
| Aug 26, 2026 | GAAP Expenses | Q4 FY2026 | $2.23B – $2.30B | New |
| Aug 26, 2026 | Non-GAAP Expenses | Q4 FY2026 | $1.45B – $1.48B | New |
| Aug 26, 2026 | Non-GAAP Interest and Other Income (Expense), net | Q4 FY2026 | -$119.00M – -$115.00M | Lowered |
| Aug 26, 2026 | Revenue | FY2026 | $9.69B – $9.74B | Raised |
| Aug 26, 2026 | Revenue | Q4 FY2026 | $2.53B – $2.58B | New |
| May 27, 2026 | Capital Expenditures | FY2026 | $300.00M | Reaffirmed |
| May 27, 2026 | Non-GAAP EPS | FY2026 | $14.72 – $14.80 | Raised |
| May 27, 2026 | Non-GAAP EPS | Q3 FY2026 | $3.63 – $3.69 | New |
| May 27, 2026 | GAAP EPS | FY2026 | $2.49 – $2.91 | Raised |
| May 27, 2026 | GAAP EPS | Q3 FY2026 | $0.84 – $0.98 | New |
| May 27, 2026 | Free Cash Flow | FY2026 | $2.00B | New |
| May 27, 2026 | Non-GAAP Tax Rate | FY2026 | 18% | Reaffirmed |
| May 27, 2026 | Operating Cash Flow | FY2026 | $2.30B | Raised |
| May 27, 2026 | Non-GAAP Tax Rate | Q3 FY2026 | 18% | New |
| May 27, 2026 | Revenue | FY2026 | $9.63B – $9.71B | Raised |
| May 27, 2026 | Revenue | Q3 FY2026 | $2.41B – $2.46B | New |
| Feb 25, 2026 | Capital Expenditures | FY2026 | $300.00M | Reaffirmed |
| Feb 25, 2026 | Non-GAAP EPS | Q2 FY2026 | $3.11 – $3.17 | New |
| Feb 25, 2026 | GAAP EPS | Q2 FY2026 | $0.23 – $0.43 | New |
| Feb 25, 2026 | Free Cash Flow | FY2026 | $1.90B | Reaffirmed |
| Feb 25, 2026 | Outstanding Shares (fully diluted) | FY2026 | 192 – 194 | New |
| Feb 25, 2026 | Non-GAAP Tax Rate | FY2026 | 18% | New |
| Feb 25, 2026 | Operating Cash Flow | FY2026 | $2.20B | Reaffirmed |
| Feb 25, 2026 | Outstanding Shares (fully diluted) | Q2 FY2026 | 192 – 194 | New |
| Feb 25, 2026 | Non-GAAP Tax Rate | Q2 FY2026 | 18% | New |
| Feb 25, 2026 | GAAP Expenses | Q2 FY2026 | $2.02B – $2.09B | New |
| Feb 25, 2026 | Non-GAAP Expenses | Q2 FY2026 | $1.38B – $1.41B | New |
| Feb 25, 2026 | Non-GAAP Interest and Other Income (Expense), net | Q2 FY2026 | -$117.00M – -$113.00M | Lowered |
| Feb 25, 2026 | Revenue | Q2 FY2026 | $2.23B – $2.28B | New |
| Dec 10, 2025 | Capital Expenditures | FY2026 | $300.00M | New |
| Dec 10, 2025 | Non-GAAP EPS | FY2026 | $14.32 – $14.40 | New |
| Dec 10, 2025 | Non-GAAP EPS | Q1 FY2026 | $3.52 – $3.58 | New |
| Dec 10, 2025 | GAAP EPS | FY2026 | $2.49 – $2.90 | New |
| Dec 10, 2025 | GAAP EPS | Q1 FY2026 | $0.22 – $0.41 | New |
| Dec 10, 2025 | Free Cash Flow | FY2026 | $1.90B | New |
| Dec 10, 2025 | Operating Cash Flow | FY2026 | $2.20B | New |
| Dec 10, 2025 | Revenue | FY2026 | $9.56B – $9.66B | New |
| Dec 10, 2025 | Revenue | Q1 FY2026 | $2.37B – $2.42B | New |
| Sep 9, 2025 | Capital Expenditures | FY2025 | $180.00M | Raised |
| Sep 9, 2025 | Non-GAAP EPS | FY2025 | $12.76 – $12.80 | Lowered |
| Sep 9, 2025 | Non-GAAP EPS | Q4 FY2025 | $2.76 – $2.80 | New |
| Sep 9, 2025 | GAAP EPS | FY2025 | $5.03 – $5.16 | Lowered |
| Sep 9, 2025 | GAAP EPS | Q4 FY2025 | -$0.27 – -$0.16 | New |
| Sep 9, 2025 | Free Cash Flow | FY2025 | $950.00M | Lowered |
| Sep 9, 2025 | Outstanding Shares (fully diluted) | FY2025 | 165 – 166 | New |
| Sep 9, 2025 | Non-GAAP Tax Rate | FY2025 | 16% | New |
| Sep 9, 2025 | Operating Cash Flow | FY2025 | $1.13B | Lowered |
| Sep 9, 2025 | GAAP Expenses | FY2025 | $6.08B – $6.10B | New |
| Sep 9, 2025 | Non-GAAP Expenses | FY2025 | $4.43B – $4.44B | New |
| Sep 9, 2025 | Non-GAAP Interest and Other Income (Expense), net | FY2025 | -$92.00M – -$94.00M | Lowered |
| Sep 9, 2025 | Outstanding Shares (fully diluted) | Q4 FY2025 | 187 – 188 | New |
| Sep 9, 2025 | Non-GAAP Tax Rate | Q4 FY2025 | 16% | New |
| Sep 9, 2025 | GAAP Expenses | Q4 FY2025 | $2.12B – $2.14B | New |
| Sep 9, 2025 | Non-GAAP Expenses | Q4 FY2025 | $1.44B – $1.45B | New |
| Sep 9, 2025 | Non-GAAP Interest and Other Income (Expense), net | Q4 FY2025 | -$179.00M – -$181.00M | Lowered |
| Sep 9, 2025 | Revenue | FY2025 | $7.03B – $7.06B | Raised |
| Sep 9, 2025 | Revenue | Q4 FY2025 | $2.23B – $2.26B | New |
| May 28, 2025 | Capital Expenditures | FY2025 | $170.00M | New |
| May 28, 2025 | Non-GAAP EPS | FY2025 | $15.11 – $15.19 | New |
| May 28, 2025 | Non-GAAP EPS | Q3 FY2025 | $3.82 – $3.87 | New |
| May 28, 2025 | GAAP EPS | FY2025 | $10.14 – $10.34 | New |
| May 28, 2025 | GAAP EPS | Q3 FY2025 | $2.63 – $2.74 | New |
| May 28, 2025 | Free Cash Flow | FY2025 | $1.30B | New |
| May 28, 2025 | Operating Cash Flow | FY2025 | $1.50B | New |
| May 28, 2025 | Revenue | FY2025 | $6.75B – $6.81B | New |
| May 28, 2025 | Revenue | Q3 FY2025 | $1.76B – $1.79B | New |
| Feb 26, 2025 | Capital Expenditures | FY2025 | $170.00M | Reaffirmed |
| Feb 26, 2025 | Non-GAAP EPS | Q2 FY2025 | $3.37 – $3.42 | New |
| Feb 26, 2025 | Non-GAAP EPS | FY2025 | $14.88 – $14.96 | Reaffirmed |
| Feb 26, 2025 | GAAP EPS | Q2 FY2025 | $2.21 – $2.33 | New |
| Feb 26, 2025 | GAAP EPS | FY2025 | $10.09 – $10.31 | Lowered |
| Feb 26, 2025 | Free Cash Flow | FY2025 | $1.60B | Reaffirmed |
| Feb 26, 2025 | Outstanding Shares (fully diluted) | Q2 FY2025 | 156 – 158 | New |
| Feb 26, 2025 | Non-GAAP Tax Rate | Q2 FY2025 | 16% | New |
| Feb 26, 2025 | GAAP Expenses | Q2 FY2025 | $1.19B – $1.21B | New |
| Feb 26, 2025 | Non-GAAP Expenses | Q2 FY2025 | $985.00M – $995.00M | New |
| Feb 26, 2025 | Non-GAAP Interest and Other Income (Expense), net | Q2 FY2025 | $24.00M – $26.00M | Lowered |
| Feb 26, 2025 | Outstanding Shares (fully diluted) | FY2025 | 157 – 159 | New |
| Feb 26, 2025 | Non-GAAP Tax Rate | FY2025 | 16% | New |
| Feb 26, 2025 | Operating Cash Flow | FY2025 | $1.80B | New |
| Feb 26, 2025 | GAAP Expenses | FY2025 | $4.97B – $5.03B | New |
| Feb 26, 2025 | Non-GAAP Expenses | FY2025 | $4.05B – $4.09B | New |
| Feb 26, 2025 | Non-GAAP Interest and Other Income (Expense), net | FY2025 | $94.00M – $98.00M | Lowered |
| Feb 26, 2025 | Revenue | Q2 FY2025 | $1.59B – $1.62B | New |
| Feb 26, 2025 | Revenue | FY2025 | $6.75B – $6.81B | Reaffirmed |
| Dec 4, 2024 | Capital Expenditures | FY2025 | $170.00M | New |
| Dec 4, 2024 | Non-GAAP EPS | Q1 FY2025 | $2.77 – $2.82 | New |
| Dec 4, 2024 | Non-GAAP EPS | FY2025 | $14.88 – $14.96 | New |
| Dec 4, 2024 | GAAP EPS | Q1 FY2025 | $1.81 – $1.95 | New |
| Dec 4, 2024 | GAAP EPS | FY2025 | $10.42 – $10.63 | New |
| Dec 4, 2024 | Free Cash Flow | FY2025 | $1.60B | New |
| Dec 4, 2024 | Revenue | Q1 FY2025 | $1.44B – $1.47B | New |
| Dec 4, 2024 | Revenue | FY2025 | $6.75B – $6.81B | New |
| Aug 21, 2024 | Capital Expenditures | FY2024 | $200.00M | Reaffirmed |
| Aug 21, 2024 | Non-GAAP EPS | Q4 FY2024 | $3.27 – $3.32 | New |
| Aug 21, 2024 | Non-GAAP EPS | FY2024 | $13.07 – $13.12 | Raised |
| Aug 21, 2024 | GAAP EPS | Q4 FY2024 | $2.25 – $2.39 | New |
| Aug 21, 2024 | GAAP EPS | FY2024 | $9.71 – $9.85 | Raised |
| Aug 21, 2024 | Free Cash Flow | FY2024 | $1.10B | Reaffirmed |
| Aug 21, 2024 | Outstanding Shares (fully diluted) | Q4 FY2024 | 155 – 157 | New |
| Aug 21, 2024 | Non-GAAP Tax Rate | Q4 FY2024 | 15% | New |
| Aug 21, 2024 | GAAP Expenses | Q4 FY2024 | $1.21B – $1.23B | New |
| Aug 21, 2024 | Non-GAAP Expenses | Q4 FY2024 | $1.03B – $1.04B | New |
| Aug 21, 2024 | Non-GAAP Interest and Other Income (Expense), net | Q4 FY2024 | $8.00M – $10.00M | Lowered |
| Aug 21, 2024 | Outstanding Shares (fully diluted) | FY2024 | 155 – 157 | Reaffirmed |
| Aug 21, 2024 | Non-GAAP Tax Rate | FY2024 | 15% | Reaffirmed |
| Aug 21, 2024 | Operating Cash Flow | FY2024 | $1.30B | Reaffirmed |
| Aug 21, 2024 | GAAP Expenses | FY2024 | $4.58B – $4.60B | Narrowed |
| Aug 21, 2024 | Non-GAAP Expenses | FY2024 | $3.76B – $3.77B | Raised |
| Aug 21, 2024 | Non-GAAP Interest and Other Income (Expense), net | FY2024 | $41.00M – $43.00M | Lowered |
| Aug 21, 2024 | Revenue | Q4 FY2024 | $1.61B – $1.64B | New |
| Aug 21, 2024 | Revenue | FY2024 | $6.11B – $6.14B | Narrowed |
| May 22, 2024 | Capital Expenditures | FY2024 | $200.00M | New |
| May 22, 2024 | Non-GAAP EPS | FY2024 | $12.90 – $12.98 | Lowered |
| May 22, 2024 | Non-GAAP EPS | Q3 FY2024 | $3.25 – $3.30 | New |
| May 22, 2024 | GAAP EPS | FY2024 | $9.14 – $9.36 | Lowered |
| May 22, 2024 | GAAP EPS | Q3 FY2024 | $2.22 – $2.35 | New |
| May 22, 2024 | Free Cash Flow | FY2024 | $1.10B | New |
| May 22, 2024 | Outstanding Shares (fully diluted) | FY2024 | 155 – 157 | Reaffirmed |
| May 22, 2024 | Non-GAAP Tax Rate | FY2024 | 15% | Reaffirmed |
| May 22, 2024 | Operating Cash Flow | FY2024 | $1.30B | Lowered |
| May 22, 2024 | GAAP Expenses | FY2024 | $4.56B – $4.61B | Lowered |
| May 22, 2024 | Non-GAAP Expenses | FY2024 | $3.77B – $3.81B | Raised |
| May 22, 2024 | Non-GAAP Interest and Other Income (Expense), net | FY2024 | $32.00M – $36.00M | Lowered |
| May 22, 2024 | Non-GAAP Tax Rate | Q3 FY2024 | 15% | New |
| May 22, 2024 | Outstanding Shares (fully diluted) | Q3 FY2024 | 155 – 157 | New |
| May 22, 2024 | GAAP Expenses | Q3 FY2024 | $1.10B – $1.12B | New |
| May 22, 2024 | Non-GAAP Expenses | Q3 FY2024 | $920.00M – $930.00M | New |
| May 22, 2024 | Non-GAAP Interest and Other Income (Expense), net | Q3 FY2024 | $4.00M – $6.00M | Lowered |
| May 22, 2024 | Revenue | FY2024 | $6.09B – $6.15B | Lowered |
| May 22, 2024 | Revenue | Q3 FY2024 | $1.51B – $1.54B | New |
| Feb 21, 2024 | Non-GAAP EPS | Q2 FY2024 | $3.09 – $3.14 | New |
| Feb 21, 2024 | Non-GAAP EPS | FY2024 | $13.47 – $13.55 | Raised |
| Feb 21, 2024 | GAAP EPS | Q2 FY2024 | $2.05 – $2.16 | New |
| Feb 21, 2024 | GAAP EPS | FY2024 | $9.56 – $9.74 | Raised |
| Feb 21, 2024 | Outstanding Shares (fully diluted) | Q2 FY2024 | 155 – 157 | New |
| Feb 21, 2024 | Non-GAAP Tax Rate | Q2 FY2024 | 15% | New |
| Feb 21, 2024 | GAAP Expenses | Q2 FY2024 | $1.21B – $1.23B | New |
| Feb 21, 2024 | Non-GAAP Expenses | Q2 FY2024 | $1.01B – $1.02B | New |
| Feb 21, 2024 | Non-GAAP Interest and Other Income (Expense), net | Q2 FY2024 | $2.00M – $4.00M | Lowered |
| Feb 21, 2024 | Outstanding Shares (fully diluted) | FY2024 | 155 – 157 | Reaffirmed |
| Feb 21, 2024 | Non-GAAP Tax Rate | FY2024 | 15% | Reaffirmed |
| Feb 21, 2024 | Operating Cash Flow | FY2024 | $1.40B | Reaffirmed |
| Feb 21, 2024 | GAAP Expenses | FY2024 | $5.02B – $5.08B | Raised |
| Feb 21, 2024 | Non-GAAP Expenses | FY2024 | $4.14B – $4.18B | Raised |
| Feb 21, 2024 | Non-GAAP Interest and Other Income (Expense), net | FY2024 | $24.00M – $28.00M | Lowered |
| Feb 21, 2024 | Revenue | Q2 FY2024 | $1.56B – $1.59B | New |
| Feb 21, 2024 | Revenue | FY2024 | $6.57B – $6.63B | Reaffirmed |
| Nov 29, 2023 | Non-GAAP EPS | Q1 FY2024 | $3.40 – $3.45 | New |
| Nov 29, 2023 | Non-GAAP EPS | FY2024 | $13.33 – $13.41 | New |
| Nov 29, 2023 | GAAP EPS | Q1 FY2024 | $2.40 – $2.50 | New |
| Nov 29, 2023 | GAAP EPS | FY2024 | $9.07 – $9.25 | New |
| Nov 29, 2023 | Outstanding Shares (fully diluted) | Q1 FY2024 | 155 – 157 | New |
| Nov 29, 2023 | Non-GAAP Tax Rate | Q1 FY2024 | 15% | New |
| Nov 29, 2023 | GAAP Expenses | Q1 FY2024 | $1.22B – $1.24B | New |
| Nov 29, 2023 | Non-GAAP Expenses | Q1 FY2024 | $1.02B – $1.03B | New |
| Nov 29, 2023 | Outstanding Shares (fully diluted) | FY2024 | 155 – 157 | New |
| Nov 29, 2023 | Non-GAAP Tax Rate | FY2024 | 15% | New |
| Nov 29, 2023 | Operating Cash Flow | FY2024 | $1.40B | New |
| Nov 29, 2023 | GAAP Expenses | FY2024 | $5.00B – $5.05B | New |
| Nov 29, 2023 | Non-GAAP Expenses | FY2024 | $4.14B – $4.18B | New |
| Nov 29, 2023 | Non-GAAP Other Income (Expense) | FY2024 | $4.00M – $8.00M | Lowered |
| Nov 29, 2023 | Revenue | Q1 FY2024 | $1.63B – $1.66B | New |
| Nov 29, 2023 | Revenue | FY2024 | $6.57B – $6.63B | New |
| Aug 16, 2023 | Non-GAAP EPS | Q4 FY2023 | $3.01 – $3.06 | New |
| Aug 16, 2023 | Non-GAAP EPS | FY2023 | $11.04 – $11.09 | Raised |
| Aug 16, 2023 | GAAP EPS | Q4 FY2023 | $2.17 – $2.28 | New |
| Aug 16, 2023 | GAAP EPS | FY2023 | $7.85 – $7.96 | Raised |
| Aug 16, 2023 | Outstanding Shares (fully diluted) | Q4 FY2023 | 155 – 157 | New |
| Aug 16, 2023 | Non-GAAP Tax Rate | Q4 FY2023 | 16% | New |
| Aug 16, 2023 | GAAP Expenses | Q4 FY2023 | $1.18B – $1.20B | New |
| Aug 16, 2023 | Non-GAAP Expenses | Q4 FY2023 | $1.01B – $1.02B | New |
| Aug 16, 2023 | Non-GAAP Other Income (Expense) | Q4 FY2023 | $1.00M – $3.00M | Lowered |
| Aug 16, 2023 | Outstanding Shares (fully diluted) | FY2023 | 155 – 157 | Lowered |
| Aug 16, 2023 | Non-GAAP Tax Rate | FY2023 | 16% | Reaffirmed |
| Aug 16, 2023 | Operating Cash Flow | FY2023 | $1.65B | Reaffirmed |
| Aug 16, 2023 | GAAP Expenses | FY2023 | $4.54B – $4.56B | Lowered |
| Aug 16, 2023 | Non-GAAP Expenses | FY2023 | $3.78B – $3.79B | Raised |
| Aug 16, 2023 | Non-GAAP Other Income (Expense) | FY2023 | $10.00M – $12.00M | Lowered |
| Aug 16, 2023 | Revenue | Q4 FY2023 | $1.57B – $1.60B | New |
| Aug 16, 2023 | Revenue | FY2023 | $5.81B – $5.84B | Raised |
| May 17, 2023 | Non-GAAP EPS | Q3 FY2023 | $2.70 – $2.75 | New |
| May 17, 2023 | Non-GAAP EPS | FY2023 | $10.77 – $10.84 | Raised |
| May 17, 2023 | GAAP EPS | Q3 FY2023 | $1.88 – $1.99 | New |
| May 17, 2023 | GAAP EPS | FY2023 | $7.44 – $7.60 | Raised |
| May 17, 2023 | non-GAAP operating margin | FY2023 | 34.5% | New |
| May 17, 2023 | Operating Cash Flow | FY2023 | $1.65B | Reaffirmed |
| May 17, 2023 | Revenue | Q3 FY2023 | $1.47B – $1.50B | New |
| May 17, 2023 | Revenue | FY2023 | $5.79B – $5.83B | Raised |
| Feb 15, 2023 | Non-GAAP EPS | Q2 FY2023 | $2.45 – $2.50 | New |
| Feb 15, 2023 | Non-GAAP EPS | FY2023 | $10.53 – $10.60 | Raised |
| Feb 15, 2023 | GAAP EPS | Q2 FY2023 | $1.62 – $1.72 | New |
| Feb 15, 2023 | GAAP EPS | FY2023 | $7.12 – $7.30 | Lowered |
| Feb 15, 2023 | Outstanding Shares (fully diluted) | Q2 FY2023 | 155 – 158 | New |
| Feb 15, 2023 | Non-GAAP Tax Rate | Q2 FY2023 | 16% | New |
| Feb 15, 2023 | GAAP Expenses | Q2 FY2023 | $1.09B – $1.11B | New |
| Feb 15, 2023 | Non-GAAP Expenses | Q2 FY2023 | $917.00M – $927.00M | New |
| Feb 15, 2023 | Non-GAAP Other Income (Expense) | Q2 FY2023 | -$1.00M – $1.00M | Lowered |
| Feb 15, 2023 | Outstanding Shares (fully diluted) | FY2023 | 155 – 158 | New |
| Feb 15, 2023 | Non-GAAP Tax Rate | FY2023 | 16% | New |
| Feb 15, 2023 | Operating Cash Flow | FY2023 | $1.65B | Lowered |
| Feb 15, 2023 | GAAP Expenses | FY2023 | $4.54B – $4.59B | New |
| Feb 15, 2023 | Non-GAAP Expenses | FY2023 | $3.81B – $3.84B | New |
| Feb 15, 2023 | Non-GAAP Other Income (Expense) | FY2023 | -$12.00M – -$8.00M | Lowered |
| Feb 15, 2023 | Revenue | Q2 FY2023 | $1.36B – $1.39B | New |
| Feb 15, 2023 | Revenue | FY2023 | $5.78B – $5.83B | Reaffirmed |
| Nov 30, 2022 | Non-GAAP EPS | Q1 FY2023 | $2.48 – $2.53 | New |
| Nov 30, 2022 | Non-GAAP EPS | FY2023 | $10.28 – $10.35 | New |
| Nov 30, 2022 | GAAP EPS | Q1 FY2023 | $1.89 – $2.00 | New |
| Nov 30, 2022 | GAAP EPS | FY2023 | $7.68 – $7.86 | New |
| Nov 30, 2022 | Operating Cash Flow | FY2023 | $1.70B | New |
| Nov 30, 2022 | Revenue | Q1 FY2023 | $1.34B – $1.37B | New |
| Nov 30, 2022 | Revenue | FY2023 | $5.78B – $5.83B | New |
| Aug 17, 2022 | Non-GAAP EPS | Q4 FY2022 | $1.80 – $1.85 | New |
| Aug 17, 2022 | Non-GAAP EPS | FY2022 | $8.80 – $8.85 | Raised |
| Aug 17, 2022 | GAAP EPS | Q4 FY2022 | $1.06 – $1.18 | New |
| Aug 17, 2022 | GAAP EPS | FY2022 | $6.37 – $6.49 | Raised |
| Aug 17, 2022 | Outstanding Shares (fully diluted) | Q4 FY2022 | 156 – 159 | New |
| Aug 17, 2022 | Non-GAAP Tax Rate | Q4 FY2022 | 18% | New |
| Aug 17, 2022 | Other Income (Expense) | Q4 FY2022 | $3.00M – $5.00M | New |
| Aug 17, 2022 | GAAP Expenses | Q4 FY2022 | $1.08B – $1.10B | New |
| Aug 17, 2022 | Non-GAAP Expenses | Q4 FY2022 | $919.00M – $929.00M | New |
| Aug 17, 2022 | Outstanding Shares (fully diluted) | FY2022 | 156 – 159 | Reaffirmed |
| Aug 17, 2022 | Non-GAAP Tax Rate | FY2022 | 18% | Reaffirmed |
| Aug 17, 2022 | Other Income (Expense) | FY2022 | $12.00M – $14.00M | Lowered |
| Aug 17, 2022 | Operating Cash Flow | FY2022 | $1.60B – $1.65B | Raised |
| Aug 17, 2022 | GAAP Expenses | FY2022 | $3.98B – $4.00B | Raised |
| Aug 17, 2022 | Non-GAAP Expenses | FY2022 | $3.40B – $3.41B | Raised |
| Aug 17, 2022 | Revenue | Q4 FY2022 | $1.26B – $1.29B | New |
| Aug 17, 2022 | Revenue | FY2022 | $5.06B – $5.09B | Raised |
| May 18, 2022 | Non-GAAP EPS | Q3 FY2022 | $2.01 – $2.06 | New |
| May 18, 2022 | Non-GAAP EPS | FY2022 | $8.63 – $8.70 | Raised |
| May 18, 2022 | GAAP EPS | Q3 FY2022 | $1.32 – $1.44 | New |
| May 18, 2022 | GAAP EPS | FY2022 | $6.22 – $6.40 | Raised |
| May 18, 2022 | Outstanding Shares (fully diluted) | Q3 FY2022 | 156 – 159 | New |
| May 18, 2022 | Non-GAAP Tax Rate | Q3 FY2022 | 18% | New |
| May 18, 2022 | GAAP Expenses | Q3 FY2022 | $981.00M – $1.00B | New |
| May 18, 2022 | Non-GAAP Expenses | Q3 FY2022 | $830.00M – $840.00M | New |
| May 18, 2022 | Outstanding Shares (fully diluted) | FY2022 | 156 – 159 | Lowered |
| May 18, 2022 | Non-GAAP Tax Rate | FY2022 | 18% | Reaffirmed |
| May 18, 2022 | Operating Cash Flow | FY2022 | $1.55B – $1.60B | Raised |
| May 18, 2022 | GAAP Expenses | FY2022 | $3.93B – $3.98B | Raised |
| May 18, 2022 | Non-GAAP Expenses | FY2022 | $3.35B – $3.38B | Raised |
| May 18, 2022 | Revenue | Q3 FY2022 | $1.21B – $1.24B | New |
| May 18, 2022 | Revenue | FY2022 | $5.00B – $5.05B | Raised |
| Feb 16, 2022 | Non-GAAP EPS | Q2 FY2022 | $2.35 – $2.40 | New |
| Feb 16, 2022 | Non-GAAP EPS | FY2022 | $7.85 – $7.92 | Raised |
| Feb 16, 2022 | GAAP EPS | Q2 FY2022 | $1.67 – $1.78 | New |
| Feb 16, 2022 | GAAP EPS | FY2022 | $5.53 – $5.72 | Raised |
| Feb 16, 2022 | Outstanding Shares (fully diluted) | Q2 FY2022 | 156 – 159 | New |
| Feb 16, 2022 | Annual non-GAAP Tax Rate | Q2 FY2022 | 18% | New |
| Feb 16, 2022 | GAAP Expenses | Q2 FY2022 | $931.00M – $951.00M | New |
| Feb 16, 2022 | Non-GAAP Expenses | Q2 FY2022 | $800.00M – $810.00M | New |
| Feb 16, 2022 | Outstanding Shares (fully diluted) | FY2022 | 157 – 160 | Reaffirmed |
| Feb 16, 2022 | Annual non-GAAP Tax Rate | FY2022 | 18% | Reaffirmed |
| Feb 16, 2022 | Other Income (Expense) | FY2022 | -$8.00M – -$4.00M | Lowered |
| Feb 16, 2022 | Operating Cash Flow | FY2022 | $1.45B – $1.50B | Raised |
| Feb 16, 2022 | GAAP Expenses | FY2022 | $3.81B – $3.86B | Raised |
| Feb 16, 2022 | Non-GAAP Expenses | FY2022 | $3.26B – $3.29B | Raised |
| Feb 16, 2022 | Revenue | Q2 FY2022 | $1.24B – $1.27B | New |
| Feb 16, 2022 | Revenue | FY2022 | $4.78B – $4.83B | Raised |
| Dec 1, 2021 | Non-GAAP EPS | Q1 FY2022 | $2.35 – $2.40 | New |
| Dec 1, 2021 | Non-GAAP EPS | FY2022 | $7.73 – $7.80 | New |
| Dec 1, 2021 | GAAP EPS | Q1 FY2022 | $1.75 – $1.92 | New |
| Dec 1, 2021 | GAAP EPS | FY2022 | $5.39 – $5.65 | New |
| Dec 1, 2021 | Outstanding Shares (fully diluted) | Q1 FY2022 | 156 – 159 | New |
| Dec 1, 2021 | Annual non-GAAP Tax Rate | Q1 FY2022 | 18% | New |
| Dec 1, 2021 | Other Income (Expense) | Q1 FY2022 | -$5.00M – -$3.00M | New |
| Dec 1, 2021 | GAAP Expenses | Q1 FY2022 | $934.00M – $964.00M | New |
| Dec 1, 2021 | Non-GAAP Expenses | Q1 FY2022 | $802.00M – $812.00M | New |
| Dec 1, 2021 | Outstanding Shares (fully diluted) | FY2022 | 157 – 160 | New |
| Dec 1, 2021 | Annual non-GAAP Tax Rate | FY2022 | 18% | New |
| Dec 1, 2021 | Other Income (Expense) | FY2022 | -$11.00M – -$7.00M | New |
| Dec 1, 2021 | Operating Cash Flow | FY2022 | $1.40B – $1.50B | Raised |
| Dec 1, 2021 | GAAP Expenses | FY2022 | $3.78B – $3.84B | New |
| Dec 1, 2021 | Non-GAAP Expenses | FY2022 | $3.23B – $3.26B | New |
| Dec 1, 2021 | Revenue | Q1 FY2022 | $1.25B – $1.28B | New |
| Dec 1, 2021 | Revenue | FY2022 | $4.73B – $4.78B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Synopsys filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Update
- Results
- News
- Results
- Update
- Results
- Update
- Results
- Update
- News
- Results
- News
- News